Development of a Collaborative European Post-Authorization Safety Study (PASS) Program Examining Rivaroxaban Use in Routine Clinical Practice
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2014)
摘要
Development of a Collaborative European Post-Authorization Safety Study (PASS) Program Examining Rivaroxaban Use in Routine Clinical Practice
更多查看译文
关键词
rivaroxaban use,clinical practice,post-authorization
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要